Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

• Status: Completed
• Trial end date: 2012-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to compare pharmacokinetics between Pitavastatin and Valsartan co-administration and Livalo fixed combination drug in healthy male subjects.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: JW Pharmaceutical
• Treatments: Pitavastatin; Valsartan

Criteria

Inclusion Criteria:

• Healthy male volunteers

• Age 20-55 years at the time of Screening

• BMI 19-26 kg/m2 at the time of Screening

Exclusion Criteria:

• Received other investigational drug within 90 days prior to the first dose of study drug